ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)

China · Delayed Price · Currency is CNY

35.34

-0.37 (-1.04%)

May 20, 2026, 1:54 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Preparations		176.71M				190.40M	128.82M	58.44M
Preparations Growth		-				47.80%	120.44%	-
Active Pharmaceutical Ingredient (API)		119.41M				64.43M	104.37M	82.57M
Active Pharmaceutical Ingredient (API) Growth		-				-38.27%	26.41%	-
Pharmaceutical Research		92.33M				36.84M	23.75M	33.57M
Pharmaceutical Research Growth		-				55.14%	-29.27%	-
Customized Production		11.09M				20.44M	10.65M	16.80M
Customized Production Growth		-				92.01%	-36.63%	-
Commissioned Processing Service		31.79M				13.22M	6.95M	1.88M
Commissioned Processing Service Growth		-				90.16%	270.13%	-
Unallocated Others		3.70M				-	-	-
Total		435.02M				325.33M	274.54M	193.26M
Total Growth		-				18.50%	42.06%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China		349.75M				297.49M	197.06M	141.25M
China Growth		-				50.96%	39.51%	-
Overseas		85.27M				27.85M	77.48M	52.01M
Overseas Growth		-				-64.06%	48.98%	-
Total		435.02M				325.33M	274.54M	193.26M
Total Growth		-				18.50%	42.06%	-

Source: S&P Global Market Intelligence.